Ex-FDA Commissioner Slams Xarelto Warnings In Philly Trial
A former Food and Drug Administration commissioner told a Philadelphia jury on Tuesday that warning labels for the blood thinner Xarelto failed to provide adequate information to doctors and consumers about...To view the full article, register now.
Already a subscriber? Click here to view full article